| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus AD Pradhan, JAE Manson, N Rifai, JE Buring, PM Ridker jama 286 (3), 327-334, 2001 | 6290 | 2001 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1328 | 2017 |
| Low-dose methotrexate for the prevention of atherosclerotic events PM Ridker, BM Everett, A Pradhan, JG MacFadyen, DH Solomon, ... New England Journal of Medicine 380 (8), 752-762, 2019 | 1260 | 2019 |
| Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial PM Ridker, A Pradhan, JG MacFadyen, P Libby, RJ Glynn The Lancet 380 (9841), 565-571, 2012 | 1085 | 2012 |
| Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study AD Pradhan, JAE Manson, JE Rossouw, DS Siscovick, CP Mouton, ... Jama 288 (8), 980-987, 2002 | 928 | 2002 |
| Triglyceride lowering with pemafibrate to reduce cardiovascular risk A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ... New England Journal of Medicine 387 (21), 1923-1934, 2022 | 496 | 2022 |
| Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis BM Everett, AD Pradhan, DH Solomon, N Paynter, J MacFadyen, ... American heart journal 166 (2), 199-207. e15, 2013 | 462 | 2013 |
| Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events AM Healy, MD Pickard, AD Pradhan, Y Wang, Z Chen, K Croce, ... Circulation 113 (19), 2278-2284, 2006 | 429 | 2006 |
| Do atherosclerosis and type 2 diabetes share a common inflammatory basis? AD Pradhan, PM Ridker European heart journal 23 (11), 831-834, 2002 | 402 | 2002 |
| Relationship of total and abdominal adiposity with CRP and IL-6 in women KM Rexrode, A Pradhan, JE Manson, JE Buring, PM Ridker Annals of epidemiology 13 (10), 674-682, 2003 | 393 | 2003 |
| Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study AD Pradhan, NP Paynter, BM Everett, RJ Glynn, P Amarenco, M Elam, ... American heart journal 206, 80-93, 2018 | 346 | 2018 |
| Sex differences in the metabolic syndrome: implications for cardiovascular health in women AD Pradhan Clinical chemistry 60 (1), 44-52, 2014 | 341 | 2014 |
| Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes BM Everett, MY Donath, AD Pradhan, T Thuren, P Pais, JC Nicolau, ... Journal of the American College of Cardiology 71 (21), 2392-2401, 2018 | 331 | 2018 |
| C-reactive protein is independently associated with fasting insulin in nondiabetic women AD Pradhan, NR Cook, JE Buring, JAE Manson, PM Ridker Arteriosclerosis, thrombosis, and vascular biology 23 (4), 650-655, 2003 | 315 | 2003 |
| Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials PM Ridker, DL Bhatt, AD Pradhan, RJ Glynn, JG MacFadyen, SE Nissen The Lancet 401 (10384), 1293-1301, 2023 | 310 | 2023 |
| Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders A Pradhan Nutrition reviews 65 (suppl_3), S152-S156, 2007 | 310 | 2007 |
| Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men AD Pradhan, N Rifai, PM Ridker Circulation 106 (7), 820-825, 2002 | 290 | 2002 |
| Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women AD Pradhan, N Rifai, JE Buring, PM Ridker The American journal of medicine 120 (8), 720-727, 2007 | 282 | 2007 |
| Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease EK Duran, AW Aday, NR Cook, JE Buring, PM Ridker, AD Pradhan Journal of the American College of Cardiology 75 (17), 2122-2135, 2020 | 267 | 2020 |
| Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial M Cohen, DL Bhatt, JH Alexander, G Montalescot, C Bode, T Henry, ... Circulation 115 (20), 2642-2651, 2007 | 229* | 2007 |
Paul M Ridker, MD, MPHEugene Braunwald Professor of Medicine, Harvard Medical SchoolOverená e-mailová adresa na: partners.org